Exploring Your Treatment Options
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
Dana-Farber Cancer Institute oncologist Sara Tolaney, MD, MPH, explains treatment options for HR+/HER2- metastatic breast cancer, including aromatase inhibitors and CDK4/6 inhibitors.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
No reviews yet